NextGen Healthcare's Return On Capital Employed Insights
Portfolio Pulse from Benzinga Insights
NextGen Healthcare (NASDAQ:NXGN) reported Q1 earnings of $6.16 million, a 124.39% increase from Q4. Sales dropped slightly to $178.21 million. The company posted a Return On Capital Employed (ROCE) of 0.01%, indicating effective capital allocation. Q1 earnings per share were $0.24, beating analyst predictions of $0.22.
July 25, 2023 | 2:47 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
NextGen Healthcare reported increased Q1 earnings and effective capital allocation, suggesting potential for future growth.
NextGen Healthcare's increased earnings and effective capital allocation, as indicated by a positive ROCE, suggest the company is operating efficiently and is likely to see future growth. This is likely to have a positive impact on the company's stock in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100